Progesterone and Resting Energy Expenditure (P4&REE)
Impact of Progesterone Substitution in Luteal Phase on Resting Energy Expenditure in Women During Menopausal Transition.
Sponsor: Insel Gruppe AG, University Hospital Bern
Terminated
massive recruitment problems became apparent because of the strict inclusion criteria of our study.
Other terminated trials from Insel Gruppe AG, University Hospital Bern
- Cerebral Vasospasm · Phase NA · Jan 2026
- Arrhythmia Burden in Patients With Recurrent, Paroxysmal Atrial Fibrillation Despite Durable Pulmonary Vein Isolation · Sep 2025
- Head and Neck Cancer · Phase NA · May 2025
- Bariatric Surgery · Phase PHASE4 · Feb 2025
- Diet, Healthy · Phase NA · Nov 2024
See all terminations from Insel Gruppe AG, University Hospital Bern
Listed as NCT04140968, this PHASE4 trial focuses on Menopause and Progesterone and remains terminated or withdrawn. Sponsored by Insel Gruppe AG, University Hospital Bern, it has been updated 8 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jul 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Apr 2022 — Jul 2023 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
▶ Show 3 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting PHASE4
-
Dec 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Insel Gruppe AG, University Hospital Bern
For direct contact, visit the study record on ClinicalTrials.gov .